Related Experiment Video
Updated: Jul 18, 2026

13:47
Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
Published on: March 29, 2019
Converting inactive peptides into potent transcriptional activators
ACS Chemical Biology
|December 19, 2006
Summary
Researchers enhanced artificial transcriptional activators by combining two binding modes. This dual-action approach significantly boosts cellular activity, improving their potential for research and therapeutics.
Area of Science:
- Molecular Biology
- Synthetic Biology
- Drug Discovery
Background:
- Artificial transcriptional activators are crucial tools in molecular biology, therapeutics, and biomanufacturing.
- Current artificial activators often lack the cellular potency of natural counterparts, limiting their effectiveness.
- Developing highly potent artificial activators remains a significant challenge in the field.
Discussion:
- This study introduces a novel strategy by superimposing two distinct binding modes for artificial transcriptional activators.
- The combined binding modes involve a masking interaction and direct interaction with the transcriptional machinery.
- This synergistic approach leads to a substantial enhancement in the cellular activity of artificial activators.
Key Insights:
- The superimposition of dual binding modes resulted in up to a 600-fold enhancement in cellular activity.
- This enhancement addresses the critical need for artificial activators with potency comparable to endogenous systems.
- The findings highlight a new design principle for engineering more effective artificial transcriptional activators.
Outlook:
- Future generations of small molecule transcriptional activators can incorporate this dual binding mode feature.
- This strategy is expected to improve nuclear uptake and target protein accessibility of artificial activators.
- The enhanced activity and utility of these engineered molecules hold promise for advanced biomanufacturing and therapeutic applications.
Related Concept Videos
Eukaryotic Transcription Activators
Transcription activators are proteins that promote the transcription of genes from DNA to RNA. In most cases, these proteins contain two separate domains ‒ a domain that binds to DNA and a domain for activating transcription; however, in some cases, a single domain is responsible for both binding and activation of transcription, as seen in the glucocorticoid receptor and MyoD.
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These domains are...
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These domains are...
Co-activators and Co-repressors
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Co-activators and Co-repressors
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
RNA Polymerase II Accessory Proteins
Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
Eukaryotic Transcription Inhibitors
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Transcription Factors
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...

